Vanguard Group Inc Care Dx, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,859,732 shares of CDNA stock, worth $114 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,859,732
Previous 4,536,178
7.13%
Holding current value
$114 Million
Previous $142 Million
26.53%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding CDNA
# of Institutions
217Shares Held
53.3MCall Options Held
53.5KPut Options Held
23.9K-
Black Rock Inc. New York, NY5.29MShares$124 Million0.0% of portfolio
-
State Street Corp Boston, MA2.66MShares$62.2 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.41MShares$56.3 Million0.45% of portfolio
-
Bamco Inc New York, NY2.21MShares$51.6 Million0.13% of portfolio
-
Fred Alger Management, LLC New York, NY1.61MShares$37.7 Million0.18% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.25B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...